A predictive medicine product for hereditary melanoma

MELARIS assesses a persons risk of developing melanoma. This test detects inherited mutations in the p16 gene (also called CDKN2A or INK4A), which occur in up to 40% of families with hereditary melanoma.

Please visit the myriadtests.com website to learn more about the melanoma form of skin cancer.

Additional Resources

Find a Provider - Search for a provider by state.
Cancer History Guide - An online family cancer history tool.
Hereditary Cancer Quiz - Check your hereditary cancer risk.

Myriadtests.com Website for Consumers
Myriadtests.com Website for Healthcare Professionals